SNY $44.92 0.51 (1.2%)

    SNY Profile

    SNY trades on the NYSE.


    Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Lantus, representing just under 10% of total sales. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of sales.

    SNY Earnings

    Q2 Earnings for Apr, May & Jun

    Mon, Jul 29, 2019

    Since Earnings Report

    SNY +6.0%

    Q3 Earnings for Jul, Aug & Sep

    Thu, Oct 31, 2019

    Since Earnings Report

    SNY +0.0%

    SNY Dividend

    Dividend Yield


    Dividend Rate


    Ex-Dividend Date

    Tue, May 7, 2019

    Dividend Pay Date

    Fri, May 31, 2019

    Dividend Payments

    18 Payments

    SNY Industry Competitors

    Johnson & Johnson
    Bristol-Myers Squibb
    Novo Nordisk A/S
    Eli Lilly
    Gilead Sciences


    Symbol MC DY Price Day YTD
    SNY $112.51 3.87% $44.92 1.2% -55.8%


    Stock Market Terms

    Remove Blur With Premium Subscription

    Symbol Surfing

    ©2020 Symbol Surfing All Rights Reserved.

    Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

    Cookies Policy Terms Of Service Privacy Policy